RSS Feeds
Search

Press releases

Press releases

Displaying 1..1 of 1 - per page
Order by
NSAID DANGERS COULD BE REDUCED WITH TDS (R) DELIVERY
The U.S. FDA this week issued new guidelines for labeling of Non-Steroidal Anti-Inflammatory Drugs (NSAID) and Acetaminophen (Paracetemol) used for pain relief and fever reduction due to concerns about overdosing and co-administration with Alcohol. TDS wo More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Spinal Muscular Atrophy - Pipeline Review, Q4 2010
Dec 2010 - 31 pages - $500
The Drug Discovery Outsourcing Market
Jan 2011 - 99 pages - $3,835
Spinal Muscular Atrophy - Pipeline Review, Q2 2011
Apr 2011 - 50 pages - $500
National Institute of Arthritis and Musculoskeletal and Skin Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2011
Aug 2011 - 53 pages - $500
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition
Jun 2010 - 160 pages - $3,995
Duchenne Muscular Dystrophy - Pipeline Review, H2 2011
Sep 2011 - 74 pages - $500
Duchenne Muscular Dystrophy - Pipeline Review, Q1 2011
Feb 2011 - 57 pages - $500
Muscular Dystrophy - Pipeline Review, Q2 2011
Jun 2011 - 107 pages - $500
Musculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid Arthritis
Oct 2010 - 169 pages - $3,500
More Related Market Research Reports >>>

Your selection

Industry sector
Drug discovery del
Combinatorial chemistry del
Therapeutic target
Musculoskeletal del
Muscular del

Browse By

Therapeutic target
Cachexia
Cervical dystonia
Inflammation
Muscular dystrophy
Myasthenia gravis
Spasticity
Year
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us